LETTER
Synthesis of Novel 2-Substituted 4-Arylpyrrole Derivatives
2743
(13) Review: (a) Krause, N.; Thorand, S. Inorg. Chim. Acta 1999,
296, 1. (b) Csákÿ, A. G.; de la Herrán, G.; Murcia, M. C.
Chem. Soc. Rev. 2010, 39, 4080.
(14) (a) Oliva, C. G.; Silva, A. M. S.; Paz, F. A. A.; Cavaleiro, J.
A. S. Synlett 2010, 1123. (b) Oliva, C. G.; Silva, A. M. S.;
Resende, D. I. S. P.; Paz, F. A. A.; Cavaleiro, J. A. S. Eur. J.
Org. Chem. 2010, 3449.
Acknowledgment
Thanks are due to the University of Aveiro, to the Portuguese Foun-
dation for Science and Technology (FCT), and FEDER for funding
the Organic Chemistry Research Unit and the Portuguese National
NMR Network. E.M.P. Silva is grateful to FCT for a Post-Doctoral
grant (SFRH/BPD/66961/2009).
(15) Typical Procedure for the Preparation of 2-(2-Aryl-3-
nitromethyl)chromones 2a–d
References and Notes
A flask containing the appropriate (E)-2-styrylchromone
1a–d (0.104 mmol), nitromethane (0.33 mL), and DBU
(3 mL, 0.021 mmol) was flushed with nitrogen and stirred
vigorously at r.t. After the appropriate time (Table 2), the
solvent was evaporated under reduced pressure. The residue
was taken in EtOAc and purified by preparative TLC on
silica. Elution with hexane–EtOAc (7:3 or 1:1) gave the
desired products 2a–d (for yields see Table 2).
(16) Physical Data of 2-(3-Nitro-2-phenylpropyl)-4H-
chromen-4-one (2a)
(1) (a) Gerwick, W. H.; Lopez, A.; Van Duyne, G. D.; Clardy,
J.; Ortiz, W.; Baez, A. Tetrahedron Lett. 1986, 27, 1979.
(b) Gerwick, A. W. H. J. Nat. Prod. 1989, 52, 252.
(c) Yoon, J. S.; Lee, M. K.; Sung, S. H.; Kim, Y. C. J. Nat.
Prod. 2006, 69, 290.
(2) (a) Gomes, A.; Freitas, M.; Fernandes, E.; Lima, J. L. F. C.
Mini-Rev. Med. Chem. 2010, 10, 1. (b) Silva, A. M. S.;
Pinto, D. C. G.; Cavaleiro, J. A. S.; Levai, A.; Patonay, T.
ARKIVOC 2004, (vii), 106.
Colourless oil. 1H NMR (300 MHz, CDCl3): d = 8.12 (1 H,
dd, J = 1.6, 8.1 Hz, H-5), 7.65 (1 H, ddd, J = 1.6, 7.0, 8.5 Hz,
H-7), 7.41–7.18 (7 H, m, H-Ph, H-6, and H-8), 6.03 (1 H, s,
H-3), 4.72 (2 H, d, J = 7.6 Hz, b-CH2NO2), 4.11–4.01 (1 H,
m, H-b), 3.09 (1 H, dd, J = 6.5, 14.5 Hz, H-a), 3.00 (1 H, dd,
J = 8.8, 14.5 Hz, H-a). 13C NMR (75 MHz, CDCl3): d =
177.7 (C-4), 164.8 (C-2), 156.2 (C-9), 137.2 (C-1¢), 133.7
(C-7), 129.2 (C-3¢,5¢), 128.3 (C-4¢), 127.2 (C-2¢,6¢), 125.7
(C-5), 125.2 (C-6), 123.5 (C-10), 117.7 (C-8), 111.8 (C-3),
79.4 (b-CH2NO2), 41.9 (C-b), 38.1 (C-a). HRMS (ESI+):
m/z calcd for C18H16NO4 [M + H]+: 310.1074; found:
310.1074.
(3) Pinto, D. C. G. A.; Silva, A. M. S.; Almeida, L. M. P. M.;
Cavaleiro, J. A. S.; Levai, A.; Patonay, T. J. Heterocycl.
Chem. 1998, 35, 217.
(4) Doria, G.; Romeo, C.; Forgione, A.; Sberze, P.; Tibolla, N.;
Corno, M. L.; Cruzzola, G.; Cadelli, G. Eur. J. Med. Chem.
1979, 347.
(5) (a) Momoi, K.; Sugita, Y.; Ishihara, M.; Satoh, K.; Kikuchi,
H.; Hashimoto, K.; Yokoe, I.; Nishikawa, H.; Fujisawa, S.;
Sakagami, H. In Vivo 2005, 19, 157. (b) Marinho, J.; Pedro,
M.; Pinto, D. C. G. A.; Silva, A. M. S.; Cavaleiro, J. A. S.;
Sunkel, C. E.; Nascimento, M. S. J. Biochem. Pharmacol.
2008, 75, 826. (c) Shaw, A. Y.; Chang, C. Y.; Liau, H. H.;
Lu, P. J.; Chen, H. L.; Yang, C. N.; Li, H. Y. Eur. J. Med.
Chem. 2009, 2552. (d) Pinto, D. C. G. A.; Silva, A. M. S.;
Cavaleiro, J. A. S. New J. Chem. 2000, 24, 85.
(6) (a) Desideri, N.; Conti, C.; Mastromarino, P.; Mastropaolo,
F. Antivir. Chem. Chemother. 2000, 11, 373. (b) Desideri,
N.; Mastromarino, P.; Conti, C. Antivir. Chem. Chemother.
2003, 14, 195. (c) Conti, C.; Mastromarino, P.; Goldoni, P.;
Portalone, G.; Desideri, N. Antivir. Chem. Chemother. 2005,
16, 267.
(7) (a) Fernandes, E.; Carvalho, F.; Silva, A. M. S.; Santos, C.
M. M.; Pinto, D. C. G. A.; Cavaleiro, J. A. S.; Bastos, M. L.
J. Enzyme Inhib. Med. Chem. 2002, 17, 45. (b) Fernandes,
E.; Carvalho, M.; Carvalho, F.; Silva, A. M. S.; Santos, C.
M. M.; Pinto, D. C. G. A.; Cavaleiro, J. A. S.; Bastos, M. L.
Arch. Toxicol. 2003, 77, 500. (c) Filipe, P.; Silva, A. M. S.;
Morliere, P.; Brito, C. M.; Patterson, L. K.; Hug, G. L.;
Silva, J. N.; Cavaleiro, J. A. S.; Maziere, J.-C.; Freitas, J. P.;
Santus, R. Biochem. Pharmacol. 2004, 67, 2207.
(d) Gomes, A.; Fernandes, E.; Silva, A. M. S.; Santos, C. M.
M.; Pinto, D. C. G. A.; Cavaleiro, J. A. S.; Lima, J. L. F. C.
Bioorg. Med. Chem. 2007, 15, 6027.
(17) Patoilo, D. T.; Silva, A. M. S.; Cavaleiro, J. A. S. Synlett
2010, 1381.
(18) (Z)-(2-Hydroxyphenyl) (4-Phenylpyrrolidin-2-
ylidene)methyl Ketone (3a)
Yellow solid; mp 113–115 °C. 1H NMR (500 MHz, CDCl3):
d = 13.80 (1 H, s, OH), 9.95 (1 H, s, NH), 7.65 (1 H, dd, J =
1.4, 8.0 Hz, H-6¢¢¢), 7.37–7.24 (6 H, m, H-Ph and H-4¢¢¢),
6.93 (1 H, dd, J = 1.0, 8.3 Hz, H-3¢¢¢), 6.82–6.79 (1 H, m, H-
5¢¢¢), 5.87 (1 H, s, H-2), 4.08 (1 H, ddd, J = 1.0, 7.7, 10.6 Hz,
H-5¢), 3.71 (1 H, dd, J = 7.7, 10.6 Hz, H-5¢), 3.64 (1 H, quin,
J = 7.7 Hz, H-4¢), 3.19 (1 H, dd, J = 7.7, 16.9 Hz, H-3¢), 2.93
(1 H, dd, J = 7.6, 16.9 Hz, H-3¢). 13C NMR (75 MHz,
CDCl3): d = 191.3 (C-1), 168.6 (C-2¢), 162.3 (C-2¢¢¢), 141.8
(C-1¢¢), 133.5 (C-4¢¢¢), 128.9 (C-3¢¢,5¢¢), 127.7 (C-6¢¢¢), 127.2
(C-4¢¢), 126.8 (C-2¢¢,6¢¢), 120.3 (C-1¢¢¢), 118.2 (C-3¢¢¢), 118.1
(C-5¢¢¢), 85.4 (C-2), 55.2 (C-5¢), 41.2 (C-3¢), 40.7 (C-4¢).
HRMS (ESI+): m/z calcd for C18H18NO2 [M + H]+: 280.1332;
found: 280.1332.
(19) Typical Procedure for the Preparation of the 2-
Substituted 4-Arylpyrrole Derivatives 3a–d Using
Method A
Ammonium formate (0.864 mmol) and Pd/C (10%; 7.0 mg)
were added to a solution of the appropriate 2-(2-aryl-3-
nitropropyl)-4H-chromen-4-one 2a–d (0.082 mmol) in
acetone (1 mL), and the reaction mixture was refluxed for 1
h. After cooling to r.t., the reaction mixture was filtered
through Celite, and the organic layer was evaporated to
dryness. The residue was purified by preparative TLC on
silica and eluted with a mixture of hexane–EtOAc (7:3) to
give 3a–d (for yields see Table 3).
(8) Gomes, A.; Fernandes, E.; Silva, A. M. S.; Pinto, D. C. G.
A.; Santos, C. M. M.; Cavaleiro, J. A. S.; Lima, J. L. F. C.
Biochem. Pharmacol. 2009, 78, 171.
(9) Karton, Y.; Jiang, J.-L.; Ji, X.-D.; Melman, N.; Olah, M. E.;
Stiles, G. L.; Jacobson, K. A. J. Med. Chem. 1996, 39, 2293.
(10) Perlmutter, P. In Conjugate Addition Reactions in Organic
Synthesis; Pergamon Press: Oxford, 1992.
(11) (a) Vuagnoux-d’Augustin, M.; Alexakis, A. Chem. Eur. J.
2007, 13, 9647. (b) Alexakis, A.; Benhaim, C. Eur. J. Org.
Chem. 2002, 3221. (c) Krause, N.; Hoffmann-Röder, A.
Synthesis 2001, 171. (d) Hayashi, T. Acc. Chem. Res. 2000,
33, 354.
(12) Almasi, D.; Alonso, D. A.; Najera, C. Tetrahedron:
Asymmetry 2007, 18, 299.
(20) Burros, A. I. R. N. A.; Silva, A. M. S. Tetrahedron Lett.
2003, 44, 5893.
(21) Typical Procedure for the Preparation of the 2-
Substituted 4-Arylpyrrole Derivatives 3a–d Using
Method B
To a solution of the appropriate 2-(2-aryl-3-nitropropyl)-4H-
Synlett 2011, No. 18, 2740–2744 © Thieme Stuttgart · New York